✦ LIBER ✦

Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era

✍ Scribed by Hideki Muramatsu; Yoshiyuki Takahashi; Hirotoshi Sakaguchi; Akira Shimada; Nobuhiro Nishio; Asahito Hama; Sayoko Doisaki; Hiroshi Yagasaki; Kimikazu Matsumoto; Koji Kato; Seiji Kojima

Book ID: 107619210
Publisher: Carden Jennings Publishing
Year: 2011
Tongue: English
Weight: 250 KB
Volume: 93
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-010-0764-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deletions of the Derivative Chromosome 9

Deletions of the Derivative Chromosome 9 Do Not Influence the Response and the Outcome of Chronic Myeloid Leukemia in Early Chronic Phase Treated With Imatinib Mesylate: GIMEMA CML Working Party Analysis

✍ Castagnetti, F.; Testoni, N.; Luatti, S.; Marzocchi, G.; Mancini, M.; Kerim, S.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 138 KB

Impact of age, leukocyte count and day 2

Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study

✍ Virginie Gandemer; Marie-Francoise Auclerc; Yves Perel; Jean-Pierre Vannier; Edo 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 521 KB